GO:0008397 sterol 12-alpha-hydroxylase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0008397 defines sterol 12-alpha-hydroxylase activity, the cytochrome P450 enzyme (CYP8B1) that adds a hydroxyl group at carbon 12 of the steroid nucleus, committing bile acid synthesis to cholic acid.
• The reaction uses a steroid substrate, reduced NADPH--hemoprotein reductase, and molecular oxygen to produce a 12-alpha-hydroxysteroid, oxidized reductase, and water.
• CYP8B1 is the principal gene encoding this activity in mammals, and its promoter is differentially regulated by SREBP-1 and SREBP-2.
• Hepatic 12-alpha-hydroxylase activity determines the ratio of cholic acid to chenodeoxycholic acid in bile, which in turn influences cholesterol homeostasis and intestinal physiology.
• Altered CYP8B1 activity and cholic acid levels contribute to intestinal epithelial injury in colitis and to cholangitis in primary biliary cholangitis models.
• Dietary and microbial factors, including quercetin-driven Akkermansia muciniphila and high-fat feeding, modulate CYP8B1 expression and bile acid composition.
Description
Sterol 12-alpha-hydroxylase activity (GO:0008397) is a molecular function that catalyzes the introduction of a hydroxyl group at the 12-alpha position of the steroid nucleus, a critical step in the biosynthesis of cholic acid, one of the primary bile acids in mammals. This activity is encoded by the cytochrome P450 family 8 subfamily B member 1 gene (CYP8B1) and is a branch-point enzyme that determines the ratio of cholic acid to chenodeoxycholic acid in the bile acid pool. Because bile acids are essential for cholesterol elimination, lipid absorption, and gut microbiome homeostasis, researchers study this activity to understand metabolic, gastrointestinal, and hepatic diseases. The enzyme requires a reduced NADPH--hemoprotein reductase and molecular oxygen, and it produces a 12-alpha-hydroxysteroid, oxidized reductase, water, and a proton. The official GO definition captures this catalytic reaction, and the synonym cytochrome P450 CYP8B1 reflects the gene product responsible for the activity in humans and rodents. This article summarizes the mechanism, key genes, disease relevance, and experimental models for studying GO:0008397, with all facts supported by published literature.
sterol 12-alpha-hydroxylase activity At A Glance
| GO ID | GO:0008397 |
|---|---|
| GO term | sterol 12-alpha-hydroxylase activity |
| Ontology | molecular_function |
| Synonym | cytochrome P450 CYP8B1 |
| Major function | Catalyzes 12-alpha-hydroxylation of steroids in bile acid biosynthesis |
| Reaction | a steroid + reduced [NADPH--hemoprotein reductase] + O2 = a 12-alpha-hydroxysteroid + oxidized [NADPH--hemoprotein reductase] + H2O + H+ |
| Cofactors | NADPH--hemoprotein reductase (reduced), molecular oxygen |
| Representative gene | CYP8B1 |
| Tissue distribution | Liver (hepatic 12-alpha-hydroxylase activity) |
What Is GO:0008397?
In simple terms, sterol 12-alpha-hydroxylase activity is the enzyme function that attaches a hydroxyl group to the 12th carbon of a steroid molecule, using oxygen and reducing equivalents from NADPH. According to the QuickGO definition, it catalyzes the reaction: a steroid + reduced [NADPH--hemoprotein reductase] + O2 = a 12-alpha-hydroxysteroid + oxidized [NADPH--hemoprotein reductase] + H2O + H+. This activity is synonymous with cytochrome P450 CYP8B1 and is a molecular function (GO:0008397) that commits bile acid synthesis toward cholic acid.
Why Is sterol 12-alpha-hydroxylase activity Important in Cell Biology?
Sterol 12-alpha-hydroxylase activity is important because it controls the synthesis of cholic acid, a primary bile acid that influences cholesterol catabolism, fat digestion, and intestinal signaling. The ratio of cholic acid to chenodeoxycholic acid, set by this enzyme, affects bile acid pool composition and has been linked to intestinal stem cell renewal, epithelial injury, and colitis severity. In addition, hepatic CYP8B1 expression is modulated by dietary sterols, bile acid feedback, and metabolic signals such as SREBP-2, making it a key node in lipid and glucose homeostasis. Dysregulation of this activity is observed in cholestatic and inflammatory liver diseases, including primary biliary cholangitis models, where high-fat diet alters bile acid composition and exacerbates cholangitis. Therefore, understanding GO:0008397 provides mechanistic insight into metabolic disease, gastrointestinal inflammation, and potential therapeutic targets.
• Determines the cholic acid to chenodeoxycholic acid ratio in bile, affecting cholesterol solubility and gallstone risk.
• Regulates bile acid pool composition, which modulates intestinal epithelial stem cell renewal and colitis susceptibility.
• Is a branch-point enzyme in the neutral bile acid synthesis pathway, controlling flux toward 12-alpha-hydroxylated bile acids.
• Is transcriptionally suppressed by SREBP-2, linking sterol sensing to bile acid diversity.
• Is modulated by dietary cholesterol and sitosterol, influencing hepatic 12-alpha-hydroxylase activity.
• Shows sex differences in hamster gallbladder bile acid composition and hepatic activity.
• Is affected by bile acid feeding, demonstrating feedback regulation.
• Contributes to cholangitis and cirrhotic changes in murine primary biliary cholangitis under high-fat diet.
• Is a target of gut microbiota-derived metabolites, such as those induced by quercetin and Akkermansia muciniphila, which alleviate obesity via CYP8B1 modulation.
• Provides a potential therapeutic node for metabolic and inflammatory diseases.
What Happens During sterol 12-alpha-hydroxylase activity?
Substrate binding and oxygen activation
In simple terms: The enzyme grabs a steroid molecule and uses oxygen to prepare it for modification.
The catalytic cycle begins when a steroid substrate binds to the active site of CYP8B1, a cytochrome P450 enzyme. The enzyme receives electrons from reduced NADPH--hemoprotein reductase to activate molecular oxygen, forming a reactive iron-oxo species that can hydroxylate the steroid nucleus. This step is essential for the subsequent 12-alpha-hydroxylation and is dependent on the availability of reducing equivalents and oxygen.
12-alpha-hydroxylation of the steroid nucleus
In simple terms: The enzyme adds a hydroxyl group to the 12th carbon of the steroid, changing its shape and properties.
The activated oxygen inserts a hydroxyl group at the 12-alpha position of the steroid substrate, converting it to a 12-alpha-hydroxysteroid. This reaction is the defining catalytic event of GO:0008397 and commits the molecule to the cholic acid branch of bile acid synthesis. The product then undergoes further enzymatic modifications to yield cholic acid.
Product release and bile acid pathway flux
In simple terms: After modification, the new 12-alpha-hydroxysteroid is released and continues down the pathway to become cholic acid.
Following hydroxylation, the 12-alpha-hydroxysteroid is released from the enzyme and proceeds through additional steps of the bile acid synthesis pathway. The activity of CYP8B1 thus determines the proportion of cholic acid relative to chenodeoxycholic acid in the final bile acid pool. Changes in this flux can alter cholesterol homeostasis and intestinal signaling.
Regulation by sterol and bile acid feedback
In simple terms: The amount of enzyme activity is adjusted based on dietary sterols and bile acids returning to the liver.
Hepatic 12-alpha-hydroxylase activity is modulated by dietary cholesterol and sitosterol, as well as by bile acid feeding, indicating feedback regulation. At the transcriptional level, SREBP-2 suppresses the CYP8B1 promoter, while SREBP-1 has differential effects, linking sterol sensing to bile acid composition. These regulatory loops help maintain bile acid homeostasis.
Key Genes Involved in GO:0008397 sterol 12-alpha-hydroxylase activity
The following genes and proteins are directly or indirectly involved in sterol 12-alpha-hydroxylase activity and its regulation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CYP8B1 | Encodes the sterol 12-alpha-hydroxylase enzyme | Primary gene for GO:0008397; target for knockout and overexpression studies |
| SREBF2 | Encodes SREBP-2, a transcription factor that suppresses CYP8B1 promoter | Regulates bile acid synthesis and cholesterol homeostasis |
| SREBF1 | Encodes SREBP-1, differentially affects CYP8B1 expression | Links lipogenesis to bile acid composition |
| NR1H4 | Encodes FXR, a nuclear receptor sensing bile acids | Feedback regulation of bile acid synthesis (implied by bile acid feeding studies) |
| CYP7A1 | Encodes cholesterol 7-alpha-hydroxylase, the rate-limiting enzyme of bile acid synthesis | Provides substrate for 12-alpha-hydroxylation; activity correlated with CYP8B1 |
| AKR1D1 | Encodes 5-beta-reductase in bile acid synthesis | Downstream of 12-alpha-hydroxylation in cholic acid synthesis (pathway context) |
| CYP27A1 | Encodes sterol 27-hydroxylase in alternative bile acid pathway | Contributes to bile acid pool composition (pathway context) |
| ABCB11 | Encodes bile salt export pump | Exports bile acids; relevant to cholestasis models |
| ABCC2 | Encodes multidrug resistance-associated protein 2 | Bile acid transport; relevant to cholestasis |
| SLC10A1 | Encodes NTCP, sodium-taurocholate cotransporting polypeptide | Hepatic bile acid uptake; relevant to bile acid pool |
| FGF19 | Encodes fibroblast growth factor 19 | Intestinal FXR target that regulates bile acid synthesis (pathway context) |
| FGFR4 | Encodes FGF receptor 4 | Mediates FGF19 signaling to suppress CYP7A1 and possibly CYP8B1 (pathway context) |
| KLB | Encodes beta-klotho | Cofactor for FGFR4 in bile acid regulation (pathway context) |
| Akkermansia muciniphila | Gut bacterium that modulates bile acid metabolism | Quercetin-driven A. muciniphila alleviates obesity via ILA/m6A/CYP8B1 signaling |
| ILA | Indole-3-lactic acid, a microbial metabolite | Part of the ILA/m6A/CYP8B1 axis in obesity |
| m6A | N6-methyladenosine RNA modification | Regulates CYP8B1 expression in the ILA/m6A/CYP8B1 pathway |
How Is sterol 12-alpha-hydroxylase activity Regulated?
Sterol 12-alpha-hydroxylase activity is regulated at multiple levels. Transcriptionally, the CYP8B1 promoter is suppressed by SREBP-2, while SREBP-1 has differential effects, linking sterol availability to bile acid composition. Dietary cholesterol and sitosterol feeding alter hepatic 12-alpha-hydroxylase activity in female hamsters, indicating sterol-responsive regulation. Bile acid feeding also modulates activity, reflecting feedback control. Additionally, sex differences in hepatic 12-alpha-hydroxylase activity have been observed in hamsters. More recently, a gut microbiota-dependent pathway involving quercetin-driven Akkermansia muciniphila, indole-3-lactic acid (ILA), and m6A modification regulates CYP8B1 expression, connecting diet and microbiome to this activity. High-fat diet also modulates bile acid composition and CYP8B1-related pathways in murine primary biliary cholangitis.
sterol 12-alpha-hydroxylase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CYP8B1 | Colitis and intestinal epithelial injury | Intestinal-specific Cyp8b1 knockout or overexpression in mice |
| CYP8B1 | Primary biliary cholangitis / cholangitis | High-fat diet-fed murine PBC model with Cyp8b1 modulation |
| CYP8B1 | Obesity and metabolic syndrome | Diet-induced obesity mouse model with Akkermansia muciniphila and quercetin treatment |
| CYP8B1 | Gallstone disease / cholesterol homeostasis | Hamster models of sex differences and dietary cholesterol feeding |
| SREBF2 | Bile acid synthesis dysregulation | SREBP-2 overexpression or knockout in hepatocytes |
Colitis and intestinal epithelial injury
Hepatic CYP8B1 and its product cholic acid potentiate intestinal epithelial injury in colitis by suppressing intestinal stem cell renewal. Elevated CYP8B1 activity increases cholic acid levels, which impair stem cell function and exacerbate colitis in mouse models. This links GO:0008397 directly to gastrointestinal inflammatory disease.
Primary biliary cholangitis and cholestasis
In murine primary biliary cholangitis, a high-fat diet modulates bile acid composition and gut microbiota, leading to severe cholangitis and cirrhotic changes. CYP8B1-dependent bile acid changes are part of this pathology, suggesting that 12-alpha-hydroxylase activity influences cholestatic liver disease progression.
Obesity and metabolic syndrome
Quercetin-driven Akkermansia muciniphila alleviates obesity by modulating bile acid metabolism via an ILA/m6A/CYP8B1 signaling pathway. This indicates that CYP8B1 activity is a downstream effector of microbial and dietary interventions in obesity.
Gallstone disease and cholesterol homeostasis
The ratio of cholic acid to chenodeoxycholic acid, determined by 12-alpha-hydroxylase activity, affects cholesterol solubility in bile. Sex differences in gallbladder bile acid composition and hepatic activity in hamsters suggest that this activity may influence gallstone formation risk. However, direct human gallstone studies are not included in the verified citations.
From sterol 12-alpha-hydroxylase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the effect of complete loss of 12-alpha-hydroxylase activity on bile acid composition? | Cyp8b1 knockout mouse (constitutive or liver-specific) |
| How does a specific point mutation in the CYP8B1 active site affect catalytic activity? | CRISPR point-mutation knock-in of mutant Cyp8b1 in hepatocytes or mice |
| What is the impact of human CYP8B1 regulatory variants on expression? | Knock-in of human promoter variants into mouse Cyp8b1 locus |
| Where is CYP8B1 protein localized in hepatocytes? | Endogenous CYP8B1 tagging with fluorescent or epitope tag via knock-in |
| Does overexpression of CYP8B1 alter bile acid pool and colitis susceptibility? | Transgenic or viral overexpression of Cyp8b1 in mouse liver |
| Can gut microbiota metabolites regulate CYP8B1 expression? | Germ-free or antibiotic-treated mice colonized with Akkermansia muciniphila |
How to Study the sterol 12-alpha-hydroxylase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Enzyme activity assay | Conversion of steroid to 12-alpha-hydroxysteroid | Comparing hepatic activity across conditions |
| RNA-seq / qPCR | CYP8B1 mRNA expression | Transcriptional regulation by SREBPs or diet |
| LC-MS bile acid profiling | Bile acid species and ratios | Assessing cholic acid/chenodeoxycholic acid ratio |
| CRISPR knockout | Loss of CYP8B1 function | Determining necessity in bile acid synthesis |
| CRISPR point mutation | Specific amino acid changes in CYP8B1 | Testing catalytic residues or regulatory sites |
| CRISPR knock-in | Tagged or humanized CYP8B1 | Localization or human variant studies |
| Overexpression | Increased CYP8B1 levels | Testing sufficiency in disease models |
| 16S rRNA sequencing | Gut microbiota composition | Linking microbiota to CYP8B1 regulation |
Enzyme activity assays
Hepatic 12-alpha-hydroxylase activity can be measured using radiolabeled or mass spectrometry-based assays that quantify the conversion of steroid substrates to 12-alpha-hydroxysteroids. Classic studies used such assays to compare activity across species, sexes, and dietary conditions.
Gene expression analysis
RNA-seq or quantitative PCR can measure CYP8B1 mRNA levels in liver or cell models. This is useful for assessing transcriptional regulation by SREBPs, bile acids, and microbial metabolites.
Bile acid profiling
Liquid chromatography-mass spectrometry (LC-MS) or gas chromatography-mass spectrometry (GC-MS) can quantify bile acid species in bile, serum, feces, or liver. The ratio of cholic acid to chenodeoxycholic acid reflects 12-alpha-hydroxylase activity.
CRISPR-based genetic models
CRISPR-Cas9 knockout, point mutation, knock-in, and overexpression models allow causal testing of CYP8B1 function in vivo and in vitro. These models can be combined with bile acid profiling and disease challenge (e.g., colitis induction) to link genotype to phenotype.
How CRISPR Can Be Used to Study GO:0008397 sterol 12-alpha-hydroxylase activity
Knockout
CRISPR-Cas9 knockout of CYP8B1 can eliminate 12-alpha-hydroxylase activity, leading to a bile acid pool devoid of cholic acid. This model is useful to test the requirement of CYP8B1 in bile acid synthesis, cholesterol homeostasis, and colitis susceptibility. Liver-specific knockout avoids developmental compensation and allows adult-stage analysis.
Point Mutation
CRISPR point mutation can introduce specific amino acid substitutions in the CYP8B1 catalytic site to dissect residues required for substrate binding or oxygen activation. Such models help validate enzymatic mechanism inferred from structural studies and can mimic human variants if present.
Knock-in
Knock-in of epitope tags, fluorescent proteins, or human regulatory sequences into the endogenous CYP8B1 locus enables real-time tracking of expression and localization without overexpression artifacts. Humanized CYP8B1 knock-in mice can be used to study human-specific regulation or drug responses.
Overexpression
CRISPR activation or transgenic overexpression of CYP8B1 increases 12-alpha-hydroxylase activity and cholic acid production. This is useful to test sufficiency in driving intestinal injury or metabolic changes, as shown by studies linking CYP8B1 and cholic acid to colitis.
How EDITGENE Supports sterol 12-alpha-hydroxylase activity Research
Researchers studying sterol 12-alpha-hydroxylase activity-related genes often need to determine whether a candidate gene is causally involved in bile acid metabolism, intestinal injury, or metabolic disease. EDITGENE provides a comprehensive suite of CRISPR services to generate precisely engineered cell and animal models, enabling rigorous functional validation of GO:0008397 and its regulatory network.
Contact EDITGENE today to design your custom CRISPR model for sterol 12-alpha-hydroxylase activity research.
Frequently Asked Questions About sterol 12-alpha-hydroxylase activity
What is sterol 12-alpha-hydroxylase activity?
It is a molecular function (GO:0008397) that catalyzes the 12-alpha-hydroxylation of steroids, a key step in cholic acid synthesis, encoded by CYP8B1.
What genes are involved in sterol 12-alpha-hydroxylase activity?
The primary gene is CYP8B1, which encodes the enzyme. Regulatory genes include SREBF1 and SREBF2, and pathway-related genes include CYP7A1 and NR1H4.
What is the reaction catalyzed by sterol 12-alpha-hydroxylase?
It converts a steroid plus reduced NADPH--hemoprotein reductase and O2 into a 12-alpha-hydroxysteroid, oxidized reductase, water, and a proton.
How is sterol 12-alpha-hydroxylase activity regulated?
It is regulated by dietary sterols, bile acid feedback, SREBP-2 suppression, and gut microbiota-derived metabolites such as ILA.
What diseases are associated with CYP8B1 and 12-alpha-hydroxylase activity?
Colitis, primary biliary cholangitis, obesity, and gallstone-related cholesterol homeostasis have been linked to this activity.
How can I measure sterol 12-alpha-hydroxylase activity in the lab?
Enzyme activity assays, bile acid profiling by LC-MS, and CYP8B1 mRNA quantification are common methods.
What is the role of CYP8B1 in bile acid synthesis?
CYP8B1 determines the ratio of cholic acid to chenodeoxycholic acid by adding a 12-alpha-hydroxyl group, directing flux toward cholic acid.
Can CRISPR be used to study sterol 12-alpha-hydroxylase activity?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable causal studies of CYP8B1 function in vitro and in vivo.
What is the connection between gut microbiota and CYP8B1?
Quercetin-driven Akkermansia muciniphila modulates bile acid metabolism via an ILA/m6A/CYP8B1 signaling pathway, linking microbiota to this activity.
Where is sterol 12-alpha-hydroxylase activity primarily found?
It is primarily a hepatic activity, measured in liver tissue of humans and animal models.
Conclusion
Sterol 12-alpha-hydroxylase activity (GO:0008397) is a pivotal molecular function in bile acid metabolism, determining the cholic acid to chenodeoxycholic acid ratio and influencing cholesterol homeostasis, intestinal health, and metabolic disease. The enzyme CYP8B1 and its regulators, such as SREBPs and gut microbiota-derived signals, form a complex network that can be dissected with modern CRISPR tools. Understanding this activity offers insights into colitis, cholangitis, obesity, and gallstone-related conditions, and provides a foundation for therapeutic targeting. EDITGENE's CRISPR services empower researchers to generate precise models for functional validation of this pathway.
References
- 1. Liu J et al.. 2025. Quercetin-Driven Akkermansia Muciniphila Alleviates Obesity by Modulating Bile Acid Metabolism via an ILA/m(6)A/CYP8B1 Signaling.. Adv Sci (Weinh) 12(12):e2412865 PMID: 39888270
- 2. Chen L et al.. 2022. Hepatic cytochrome P450 8B1 and cholic acid potentiate intestinal epithelial injury in colitis by suppressing intestinal stem cell renewal.. Cell Stem Cell 29(9):1366-1381.e9 PMID: 36055192
- 3. Einarsson K et al.. 1992. 12 alpha-hydroxylase activity in human liver and its relation to cholesterol 7 alpha-hydroxylase activity.. J Lipid Res 33(11):1591-5 PMID: 1464742
- 4. Kuroki S et al.. 1983. Effect of bile acid feeding on hepatic steroid 12 alpha-hydroxylase activity in hamsters.. Lipids 18(11):789-94 PMID: 6418999
- 5. Kuroki S et al.. 1983. Sex differences in gallbladder bile acid composition and hepatic steroid 12 alpha-hydroxylase activity in hamsters.. J Lipid Res 24(12):1543-9 PMID: 6421973
- 6. Kuroki S et al.. 1983. Effect of feeding cholesterol and sitosterol on hepatic steroid 12 alpha-hydroxylase activity in female hamsters.. J Pharmacobiodyn 6(8):551-7 PMID: 6417316
- 7. del Castillo-Olivares A et al.. 2002. Differential effects of sterol regulatory binding proteins 1 and 2 on sterol 12 alpha-hydroxylase. SREBP-2 suppresses the sterol 12 alpha-hydroxylase promoter.. J Biol Chem 277(8):6750-7 PMID: 11741989
- 8. Umemura M et al.. 2024. High-fat diet modulates bile acid composition and gut microbiota, affecting severe cholangitis and cirrhotic change in murine primary biliary cholangitis.. J Autoimmun 148:103287 PMID: 39033687
